Retatrutide in type 2 diabetes mellitus and obesity: an overview.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Retatrutide in type 2 diabetes mellitus and obesity: an overview.
- Published In:
- Expert review of clinical pharmacology (2026)
- Authors:
- Panou, Theodoros(2), Gouveri, Evanthia(3), Popovic, Djordje S(7), Papanas, Nikolaos
- Database ID:
- RPEP-15859
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15859APA
Panou, Theodoros; Gouveri, Evanthia; Popovic, Djordje S; Papanas, Nikolaos. (2026). Retatrutide in type 2 diabetes mellitus and obesity: an overview.. Expert review of clinical pharmacology. https://doi.org/10.1080/17512433.2026.2642415
MLA
Panou, Theodoros, et al. "Retatrutide in type 2 diabetes mellitus and obesity: an overview.." Expert review of clinical pharmacology, 2026. https://doi.org/10.1080/17512433.2026.2642415
RethinkPeptides
RethinkPeptides Research Database. "Retatrutide in type 2 diabetes mellitus and obesity: an over..." RPEP-15859. Retrieved from https://rethinkpeptides.com/research/panou-2026-retatrutide-in-type-2
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.